Gene Set | Leading Edge Genes |
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 13 | UQCR, TCEB2, NDUFB8, GPX4, PARK7, MRPS33, DYNLRB1, NCBP2, MRPL18, TSEN34, ATP5O, HDDC2, CYB5B, GUK1, UQCRC2, CCDC56, ECH1, NDUFC1, TIMM8B, EBP |
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN UP | NDUFV2, SCAND1, GIPC1, MAP2K2, NSDHL, UQCRC1, CDK2AP2, DCXR, MBD3, DPAGT1, PSMD13, HEXIM1, DHCR24, DDT, PSMB3, HMGCS1, EBP, HMBS |
ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UP | VAMP5, PAPSS1, AP1S1, LMNA, MRPL40, MAP2K2, SDF2L1, NCBP2, PPP1CA, CCNA2, ICT1, NDUFA8, PSMD2, PSMD6, TOM1L1, IDI1, SURF1 |
RHEIN ALL GLUCOCORTICOID THERAPY DN | ATP5C1, COPS6, TUFM, MRPS33, GLO1, ADSL, MRPS35, NDUFA8, BIRC5 |
REACTOME CHOLESTEROL BIOSYNTHESIS | FDFT1, IDI1, HMGCS1, DHCR7, NSDHL |
REACTOME CELL CYCLE MITOTIC | |
REACTOME REGULATION OF INSULIN SECRETION | |
SCHLOSSER SERUM RESPONSE AUGMENTED BY MYC | |
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA DN | |
GRADE COLON CANCER UP | |
KEGG TERPENOID BACKBONE BIOSYNTHESIS | |
BORCZUK MALIGNANT MESOTHELIOMA UP | |
YU MYC TARGETS UP | |
HONMA DOCETAXEL RESISTANCE | |
MORI PLASMA CELL UP | |
CHIANG LIVER CANCER SUBCLASS UNANNOTATED DN | |
PAL PRMT5 TARGETS UP | PRKCDBP, PSMD6, TMPO, TUFM, PSMC3, NCBP2, TARDBP, ECH1, MRPL20, LSM2, NDE1, TSEN34 |
HORIUCHI WTAP TARGETS DN | |
PENG LEUCINE DEPRIVATION DN | |
UDAYAKUMAR MED1 TARGETS UP | |
KEGG PARKINSONS DISEASE | |
MORI LARGE PRE BII LYMPHOCYTE UP | |
KEGG HUNTINGTONS DISEASE | |
NUYTTEN EZH2 TARGETS DN | |
PENG GLUTAMINE DEPRIVATION DN | |
MARKEY RB1 ACUTE LOF DN | |
DAIRKEE TERT TARGETS UP | |